Patents by Inventor Francisco Javier Guenaga

Francisco Javier Guenaga has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-glycan deleted HIV-1 envelope glycoprotein trimers
    Patent number: 10870683
    Abstract: The present application relates to novel HIV-1 envelope glycoproteins which may be utilized as an HIV-1 vaccine immunogens, antigens for crystallization and for the identification of broad neutralizing antibodies. The present invention encompasses the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.
    Type: Grant
    Filed: September 13, 2018
    Date of Patent: December 22, 2020
    Assignees: INTERNATIONAL AIDS VACCINE INITIATIVE, THE SCRIPPS RESEARCH INSTITUTE
    Inventors: Viktoriya Dubrovskaya, Francisco Javier Guenaga, Richard Wyatt
  • N-GLYCAN DELETED HIV-1 ENVELOPE GLYCOPROTEIN TRIMERS
    Publication number: 20190135872
    Abstract: The present application relates to novel HIV-1 envelope glycoproteins which may be utilized as an HIV-1 vaccine immunogens, antigens for crystallization and for the identification of broad neutralizing antibodies. The present invention encompasses the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.
    Type: Application
    Filed: September 13, 2018
    Publication date: May 9, 2019
    Inventors: Viktoriya Dubrovskaya, Francisco Javier Guenaga, Richard Wyatt
  • Soluble HIV-1 envelope glycoprotein trimers
    Patent number: 10174292
    Abstract: The present application relates to novel HIV-1 envelope glycoproteins which may be utilized as an HIV-1 vaccine immunogens, antigens for crystallization and for the identification of broad neutralizing antibodies. The present invention encompasses the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.
    Type: Grant
    Filed: March 21, 2016
    Date of Patent: January 8, 2019
    Assignees: International AIDS Vaccine Initiative, The Scripps Research Institute
    Inventors: Viktoriya Dubrovskaya, Francisco Javier Guenaga, Richard Wyatt
  • SOLUBLE HIV-1 ENVELOPE GLYCOPROTEIN TRIMERS
    Publication number: 20160272948
    Abstract: The present application relates to novel HIV-1 envelope glycoproteins which may be utilized as an HIV-1 vaccine immunogens, antigens for crystallization and for the identification of broad neutralizing antibodies. The present invention encompasses the preparation and purification of immunogenic compositions which are formulated into the vaccines of the present invention.
    Type: Application
    Filed: March 21, 2016
    Publication date: September 22, 2016
    Inventors: Viktoriya Dubrovskaya, Francisco Javier Guenaga, Richard Wyatt